Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

CompletedOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
HypertensionCardiovascular Disease
Trial Locations (56)

Unknown

Research Site, Avesta

Research Site, Älvdalen

Research Site, Ängelholm

Research Site, Åkersberga

Research Site, Bengtsfors

Research Site, Borlänge

Research Site, Falun

Research Site, Farsta

Research Site, Fritsla

Research Site, Gagnef

Research Site, Gävle

Research Site, Gothenburg

Research Site, Grängesberg

Research Site, Grycksbo

Research Site, Hallstahammar

Research Site, Hägersten

Research Site, Hässelby

Research Site, Hedemora

Research Site, Helsingborg

Research Site, Henån

Research Site, Höllviken

Research Site, Jarfalla

Research Site, Kil

Research Site, Kolbäck

Research Site, Kolsva

Research Site, Köping

Research Site, Leksand

Research Site, Lidköping

Research Site, Likenäs

Research Site, Limhamn

Research Site, Ludvika

Research Site, Malmo

Research Site, Malung

Research Site, Mora

Research Site, Munka-Ljungby

Research Site, Norberg

Research Site, Sala

Research Site, Säter

Research Site, Skanör

Research Site, Skepplanda

Research Site, Skinnskatteberg

Research Site, Skogås

Research Site, Skoghall

Research Site, Skövde

Research Site, Skultuna

Research Site, Smedjebacken

Research Site, Stockholm

Research Site, Stora Höga

Research Site, Sunnansjö

Research Site, Sunne

Research Site, Svärdsjö

Research Site, Trollhättan

Research Site, Upplands Vasby

Research Site, Uppsala

Research Site, Vansbro

Research Site, Västerås

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY